IVOSX | VMVAX | IVOSX / VMVAX | |
Total Expense Ratio | 0.73 | 0.07 | 1,043% |
Annual Report Gross Expense Ratio | 0.93 | 0.07 | 1,329% |
Fund Existence | 11 years | 14 years | - |
Gain YTD | -13.371 | -12.203 | 110% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 805M | 29.9B | 3% |
Annual Yield % from dividends | 1.81 | 2.33 | 78% |
Returns for 1 year | -18.16 | -7.74 | 235% |
Returns for 3 years | -11.26 | -4.36 | 258% |
Returns for 5 years | 41.34 | 58.36 | 71% |
Returns for 10 years | 57.55 | 55.65 | 103% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FMET | 27.31 | 2.88 | +11.79% |
Fidelity Metaverse ETF | |||
FNDX | 22.47 | 1.63 | +7.82% |
Schwab Fundamental U.S. Large CompanyETF | |||
GGZ | 11.15 | 0.53 | +4.99% |
Gabelli Global Small and Mid Cap Value Trust (The) | |||
DNOV | 41.38 | 1.79 | +4.52% |
FT Vest US Equity Deep Bffr ETF Nov | |||
NRK | 10.01 | 0.11 | +1.11% |
Nuveen New York AMT-Free Quality Municipal Income Fund |